Home / LPCN : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does LPCN make money? Does LPCN have pricing power? What's the Earnings Whisper? Will LPCN profit more as the business scales? What is LPCN's management track record? Is LPCN's current price justified?

Lipocine Inc.

$2.27 -$5.73 (-71.62%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$2.25

Day Range

$2.25$2.29

Year Range

$1.81$12.37

Market Cap

18.71M

AVG Volume

64.88K

Trailing/Forward PE

-1.21/-

PEG ratio

-0.19

Dividend Yield

Next Earnings Date

2026-11-05

Primary Exchange

NASDAQ

Revenue (USD)

LPCN Revenue (USD) by year
Period	Revenue (USD)
2025	1.98M
2024	11.2M
2023	-2.85M
2022	500K
2021	16.14M
2020	0
2019	164.99K
2018	428.03K
2017	0
2016	0

Net Income (USD)

LPCN Net Income (USD) by year
Period	Net Income (USD)
2025	-9.63M
2024	8.35K
2023	-16.35M
2022	-10.76M
2021	-634.4K
2020	-20.96M
2019	-13.01M
2018	-11.66M
2017	-20.98M
2016	-18.97M

Operating Income (USD)

LPCN Operating Income (USD) by year
Period	Operating Income (USD)
2025	-10.37M
2024	-1.16M
2023	-17.93M
2022	-12.12M
2021	3.15M
2020	-18M
2019	-12.9M
2018	-11.33M
2017	-21.22M
2016	-18.46M

EBITDA (USD)

LPCN EBITDA (USD) by year
Period	EBITDA (USD)
2025	-9.57M
2024	50.14K
2023	-16.32M
2022	-10.72M
2021	-430.53K
2020	-20.57M
2019	-12.88M
2018	-10.96M
2017	-21.07M
2016	-18.43M

Cash Flows (USD)

LPCN Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-9.76M
2024	-1.31M
2023	-11.88M
2022	-12.1M
2021	-4.42M
2020	-15.3M
2019	-11.67M
2018	-12.08M
2017	-16.7M
2016	-18.28M

EPS (USD)

LPCN EPS (USD) by year
Period	EPS (USD)
2025	-1.77
2024	0
2023	-3.11
2022	-2.17
2021	-0.29
2020	-6.93
2019	-8.68
2018	-9.4
2017	-17.85
2016	-17.79

Expenses (USD)

LPCN Expenses (USD) by year
Period	Expenses (USD)
2025	12.35M
2024	10.57M
2023	10.9M
2022	8.18M
2021	6.92M
2020	10.76M
2019	13.07M
2018	11.75M
2017	21.22M
2016	18.46M

Cash & Debt (USD)

LPCN Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	14.93M
2024	21.63M
2023	22.04M
2022	32.53M
2021	44.62M
2020	19.67M
2019	14.07M
2018	15.25M
2017	21.47M
2016	26.84M

Debt ratios

LPCN Debt ratios by year
Period	Debt ratios
2025	0.4
2024	0.79
2023	0.46
2022	0.73
2021	0.94
2020	0.21
2019	0.11
2018	0.08

Margins

LPCN Margins by year
Period	Margins
2025	-8.86%
2024	83.26%
2023	188.23%
2022	-1233.79%
2021	62.3%
2019	-1016.02%
2018	100%

Return on Capital

LPCN Return on Capital by year
Period	Return on Capital
2025	-66.5%
2024	0.04%
2023	-80.28%
2022	-30.19%
2021	-1.39%
2020	-136.65%
2019	-206.87%
2018	-123.6%
2017	-110.55%
2016	-72.92%

Shares Outstanding

LPCN Shares Outstanding by year
Period	Shares Outstanding
2025	5.45M
2024	5.34M
2023	5.29M
2022	5.16M
2021	5.19M
2020	3.92M
2019	1.8M
2018	1.27M
2017	1.25M
2016	1.08M

Book Value Per Share (USD)

LPCN Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	2.66
2024	3.93
2023	3.85
2022	6.9
2021	8.77
2020	3.91
2019	3.49
2018	7.45
2017	15.21
2016	24.2

Total Assets (USD)

LPCN Total Assets (USD) by year
Period	Total Assets (USD)
2025	17.01M
2024	22.51M
2023	23M
2022	37.54M
2021	52.48M
2020	25.35M
2019	19.66M
2018	20.85M
2017	25.33M
2016	27.34M

Employee Count

LPCN Employee Count by year
Period	Employee Count
2025	14
2024	16
2023	17
2022	17
2021	13
2020	11
2019	12
2018	10
2017	14
2016	14

PE Ratio

LPCN PE Ratio by year
Period	PE Ratio
May 25	2135.07
Apr 25	2039.18
Apr 25	1917.73
Apr 25	1962.48
Apr 25	1924.12
Mar 25	2096.72
Mar 25	2262.92
Mar 25	2141.46
Mar 23	8.42
Feb 23	8.25
Feb 23	9.6
Feb 23	10.15
Feb 23	10.56
Jan 23	10.27
Jan 23	10.37
Jan 23	10.67
Jan 23	9.21
Dec 22	7.64
Dec 22	7.79
Dec 22	8.16
Dec 22	7.78
Dec 22	8.64
Nov 22	9.16
Nov 22	9.21
Nov 22	7.32
Nov 22	8.47
Oct 22	8.84
Oct 22	9.44
Oct 22	9.63
Oct 22	9.74
Sep 22	9.63
Sep 22	10.63
Sep 22	12.13
Sep 22	11.03
Sep 22	12.2
Aug 22	12.52
Aug 22	13.05
Aug 22	15.1

Free Cash Flow Yield

LPCN Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-60%
Sep 26	-55.59%
Aug 26	-62.76%
Aug 26	-65.16%
Aug 26	-64.55%
Aug 26	-63.94%
Jul 26	-69.76%
Jul 26	-71.1%
Jul 26	-66.31%
Jul 26	-61.36%
Jul 26	-61.88%
Jun 26	-60.11%
Jun 26	-63.47%
Jun 26	-65.43%
Jun 26	-72.14%
May 26	-65.73%
May 26	-65.43%
May 26	-65.43%
May 26	-62.4%
May 26	-76.88%
Apr 26	-74.02%
Apr 26	-73.72%
Apr 26	-81.42%
Apr 26	-87.38%
Mar 26	-25.05%
Mar 26	-25.05%
Mar 26	-24.41%
Mar 26	-11.7%
Feb 26	-9.55%
Feb 26	-9.71%
Feb 26	-10.98%
Feb 26	-11.2%
Jan 26	-10.57%
Jan 26	-8.72%
Jan 26	-8.55%
Jan 26	-11.88%
Jan 26	-11.89%
Dec 25	-18.19%
Dec 25	-22.38%
Dec 25	-30.01%
Dec 25	-30.2%
Nov 25	-27.65%
Nov 25	-30.1%
Nov 25	-33.14%
Nov 25	-37.45%
Oct 25	-35.66%
Oct 25	-32.71%
Oct 25	-31.41%
Oct 25	-30.6%
Oct 25	-28.31%
Sep 25	-34.75%
Sep 25	-32.94%
Sep 25	-31.83%
Sep 25	-32.82%
Aug 25	-32.6%
Aug 25	-30.5%
Aug 25	-31.3%
Aug 25	-32.37%
Aug 25	-33.76%
Jul 25	-30.92%
Jul 25	-34.09%
Jul 25	-32.52%
Jul 25	-34.31%
Jun 25	-32.32%
Jun 25	-32.23%
Jun 25	-34.09%
Jun 25	-33.55%
May 25	-31.46%
May 25	-29.71%
May 25	-26.65%
May 25	-32.42%
May 25	-7.35%
Apr 25	-7.7%
Apr 25	-8.19%
Apr 25	-8%
Apr 25	-8.16%
Mar 25	-7.49%
Mar 25	-6.94%
Mar 25	-7.33%
Mar 25	-27.37%
Feb 25	-30.67%
Feb 25	-27.85%
Feb 25	-25.93%
Feb 25	-26.9%
Jan 25	-21.79%
Jan 25	-20.07%
Jan 25	-21.54%
Jan 25	-19.25%
Jan 25	-18.61%
Dec 24	-19.78%
Dec 24	-19.33%
Dec 24	-18.75%
Dec 24	-18.46%
Nov 24	-20.74%
Nov 24	-18.28%
Nov 24	-19.25%
Nov 24	-19.78%
Nov 24	-14.55%
Oct 24	-15.33%
Oct 24	-16.92%

Price to Sales

LPCN Price to Sales by year
Period	Price to Sales
Sep 26	11.88
Sep 26	12.83
Aug 26	11.36
Aug 26	10.94
Aug 26	11.05
Aug 26	11.15
Jul 26	7.19
Jul 26	7.06
Jul 26	7.57
Jul 26	8.18
Jul 26	8.11
Jun 26	8.35
Jun 26	7.91
Jun 26	7.67
Jun 26	6.96
May 26	7.64
May 26	7.67
May 26	7.67
May 26	8.04
May 26	6.42
Apr 26	6.67
Apr 26	6.7
Apr 26	6.06
Apr 26	5.65
Mar 26	19.71
Mar 26	19.71
Mar 26	20.23
Mar 26	10.18
Feb 26	12.47
Feb 26	12.27
Feb 26	10.84
Feb 26	10.63
Jan 26	11.27
Jan 26	13.66
Jan 26	13.94
Jan 26	10.03
Jan 26	10.02
Dec 25	6.55
Dec 25	5.32
Dec 25	3.97
Dec 25	3.94
Nov 25	4.31
Nov 25	3.96
Nov 25	3.59
Nov 25	3.18
Oct 25	3.38
Oct 25	3.69
Oct 25	3.84
Oct 25	3.94
Oct 25	4.26
Sep 25	3.47
Sep 25	3.66
Sep 25	3.79
Sep 25	3.68
Aug 25	3.7
Aug 25	3.96
Aug 25	3.85
Aug 25	3.73
Aug 25	4.58
Jul 25	5.01
Jul 25	4.54
Jul 25	4.76
Jul 25	4.51
Jun 25	4.79
Jun 25	4.8
Jun 25	4.54
Jun 25	4.61
May 25	4.92
May 25	5.21
May 25	5.81
May 25	4.77
May 25	1.59
Apr 25	1.52
Apr 25	1.43
Apr 25	1.46
Apr 25	1.44
Mar 25	1.56
Mar 25	1.69
Mar 25	1.6
Mar 25	2.32
Feb 25	2.07
Feb 25	2.28
Feb 25	2.45
Feb 25	2.36
Jan 25	2.92
Jan 25	3.17
Jan 25	2.95
Jan 25	3.3
Jan 25	3.42
Dec 24	3.21
Dec 24	3.29
Dec 24	3.39
Dec 24	3.44
Nov 24	3.06
Nov 24	3.48
Nov 24	3.3
Nov 24	3.21
Nov 24	6.77
Oct 24	6.42
Oct 24	5.82

EV/EBITDA

LPCN EV/EBITDA by year
Period	EV/EBITDA
May 25	-75.81
Apr 25	-91.79
Apr 25	-112.02
Apr 25	-104.56
Apr 25	-110.95
Mar 25	-82.2
Mar 25	-54.52
Mar 25	-74.75
Mar 23	0.06
Feb 23	-0.11
Feb 23	1.21
Feb 23	1.76
Feb 23	2.16
Jan 23	1.88
Jan 23	1.97
Jan 23	2.27
Jan 23	0.84
Dec 22	-0.71
Dec 22	-0.56
Dec 22	-0.2
Dec 22	-0.58
Dec 22	0.27
Nov 22	0.78
Nov 22	0.84
Nov 22	-1.03
Nov 22	-2.38
Oct 22	-2.02
Oct 22	-1.44
Oct 22	-1.26
Oct 22	-1.15
Sep 22	-1.26
Sep 22	-0.28
Sep 22	1.17
Sep 22	0.1
Sep 22	1.23
Aug 22	1.55
Aug 22	2.06
Aug 22	4.05

Price to Book

LPCN Price to Book by year
Period	Price to Book
Sep 26	0.86
Sep 26	0.92
Aug 26	0.82
Aug 26	0.79
Aug 26	0.8
Aug 26	0.8
Jul 26	0.63
Jul 26	0.62
Jul 26	0.66
Jul 26	0.72
Jul 26	0.71
Jun 26	0.73
Jun 26	0.69
Jun 26	0.67
Jun 26	0.61
May 26	0.67
May 26	0.67
May 26	0.67
May 26	0.71
May 26	0.88
Apr 26	0.91
Apr 26	0.91
Apr 26	0.83
Apr 26	0.77
Mar 26	2.69
Mar 26	2.69
Mar 26	2.76
Mar 26	3.11
Feb 26	3.81
Feb 26	3.75
Feb 26	3.31
Feb 26	3.25
Jan 26	3.44
Jan 26	4.18
Jan 26	4.26
Jan 26	3.07
Jan 26	3.06
Dec 25	2
Dec 25	1.63
Dec 25	1.21
Dec 25	1.21
Nov 25	1.32
Nov 25	1.21
Nov 25	1.1
Nov 25	0.97
Oct 25	0.83
Oct 25	0.91
Oct 25	0.94
Oct 25	0.97
Oct 25	1.05
Sep 25	0.85
Sep 25	0.9
Sep 25	0.93
Sep 25	0.9
Aug 25	0.91
Aug 25	0.97
Aug 25	0.95
Aug 25	0.92
Aug 25	0.88
Jul 25	0.96
Jul 25	0.87
Jul 25	0.91
Jul 25	0.86
Jun 25	0.92
Jun 25	0.92
Jun 25	0.87
Jun 25	0.88
May 25	0.94
May 25	1
May 25	1.11
May 25	0.91
May 25	0.85
Apr 25	0.81
Apr 25	0.76
Apr 25	0.78
Apr 25	0.77
Mar 25	0.83
Mar 25	0.9
Mar 25	0.85
Mar 25	0.96
Feb 25	0.86
Feb 25	0.95
Feb 25	1.02
Feb 25	0.98
Jan 25	1.21
Jan 25	1.31
Jan 25	1.22
Jan 25	1.37
Jan 25	1.42
Dec 24	1.33
Dec 24	1.36
Dec 24	1.4
Dec 24	1.43
Nov 24	1.27
Nov 24	1.44
Nov 24	1.37
Nov 24	1.33
Nov 24	1.53
Oct 24	1.45
Oct 24	1.32

No video analysis for this stock yet. Request one from our team.

News: LPCN

prnewswire.com · 10 Sep 2026

Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference

SALT LAKE CITY, Sept. 10, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that Company management will present and meet with investors at the H.C.

prnewswire.com · 4 Aug 2026

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026

SALT LAKE CITY, Aug. 4, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced financial results for the second quarter ended June 30, 2026 and provided a corporate update. Recent Developments and Corporate Update LPCN 1154 (BRLIZIO™) for Postpartum Depression (PPD) On April 2, 2026, Lipocine reported topline results from its Phase 3 placebo-controlled trial (N=90) evaluating oral LPCN 1154 (oral brexanolone) for the treatment of PPD.

prnewswire.com · 3 Aug 2026

Lipocine Appoints Michael J. Grissinger to Board of Directors

SALT LAKE CITY, Aug. 3, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced the appointment of Michael J. Grissinger to its Board of Directors, effective August 3, 2026.